We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved heal... ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential. Show more
FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ophthalmology, CNS (central...
ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received based on Executed Global Licensing Agreements that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0045 | -0.925925925926 | 0.486 | 0.52 | 0.4236 | 1221960 | 0.51754107 | CS |
4 | -0.0385 | -7.40384615385 | 0.52 | 0.59 | 0.4236 | 354426 | 0.51830784 | CS |
12 | -0.2066 | -30.0247057114 | 0.6881 | 0.77 | 0.4053 | 254964 | 0.57359488 | CS |
26 | -0.3845 | -44.3995381062 | 0.866 | 0.969 | 0.4053 | 161982 | 0.62539012 | CS |
52 | -0.8285 | -63.2442748092 | 1.31 | 2.45 | 0.4053 | 810005 | 1.50897438 | CS |
156 | -32.6185 | -98.5453172205 | 33.1 | 40.5 | 0.4053 | 654197 | 3.44287145 | CS |
260 | -32.7185 | -98.5496987952 | 33.2 | 116.883 | 0.4053 | 867083 | 17.06372913 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions